{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:31:38Z","timestamp":1779179498028,"version":"3.51.4"},"reference-count":50,"publisher":"The Endocrine Society","issue":"7","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR059357"],"award-info":[{"award-number":["R01-AR059357"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-AR065971"],"award-info":[{"award-number":["T32-AR065971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Administration","award":["I01 BX002104"],"award-info":[{"award-number":["I01 BX002104"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1210\/en.2019-00237","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T09:09:44Z","timestamp":1557738584000},"page":"1659-1673","source":"Crossref","is-referenced-by-count":25,"title":["Glucocorticoid-Induced Bone Fragility Is Prevented in Female Mice by Blocking Pyk2\/Anoikis Signaling"],"prefix":"10.1210","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-1369","authenticated-orcid":false,"given":"Amy Y","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meloney","family":"Cregor","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"McAndrews","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith W","family":"Condon","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian I","family":"Plotkin","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-7004","authenticated-orcid":false,"given":"Teresita","family":"Bellido","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana"},{"name":"Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"},{"name":"Indiana Center for Musculoskeletal Health, Indianapolis, Indiana"},{"name":"Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,5,13]]},"reference":[{"issue":"16","key":"2019062417101274100_bib1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2019062417101274100_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1513\/pats.200402-005MS","article-title":"Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells","volume":"1","author":"Necela","year":"2004","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"2019062417101274100_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00223-012-9630-5","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"91","author":"Rizzoli","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2019062417101274100_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2019062417101274100_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis","volume":"79","author":"van Staa","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2019062417101274100_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bjh.14452","article-title":"Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma","volume":"176","author":"Littooij","year":"2017","journal-title":"Br J Haematol"},{"issue":"8299","key":"2019062417101274100_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","article-title":"Cushing\u2019s syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis","volume":"2","author":"Ross","year":"1982","journal-title":"Lancet"},{"issue":"6","key":"2019062417101274100_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019062417101274100_bib9","unstructured":"Davis\n              K\n            , NeeseK, SoodA. FDA approves Prolia (denosumab) for glucocorticoid-induced osteoporosis. Available at: https:\/\/www.amgen.com\/media\/news-releases\/2018\/05\/fda-approves-prolia-denosumab-for-glucocorticoidinduced-osteoporosis\/. Accessed 13 May 2019."},{"issue":"5","key":"2019062417101274100_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"2019062417101274100_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2015.03.002","article-title":"Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial","volume":"75","author":"Mok","year":"2015","journal-title":"Bone"},{"issue":"20","key":"2019062417101274100_bib12","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"2019062417101274100_bib13","first-page":"49","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone","volume":"4","author":"Allen","year":"2007","journal-title":"Int Bone Mineral Soc Knowl Environ"},{"issue":"7","key":"2019062417101274100_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator","volume":"67","author":"O\u2019Ryan","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2019062417101274100_bib15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O\u2019Brien","year":"2004","journal-title":"Endocrinology"},{"issue":"12","key":"2019062417101274100_bib16","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"issue":"8","key":"2019062417101274100_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"2019062417101274100_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12018-018-9242-3","article-title":"Glucocorticoid excess in bone and muscle","volume":"16","author":"Sato","year":"2018","journal-title":"Clin Rev Bone Miner Metab"},{"key":"2019062417101274100_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-416015-6.00002-2","article-title":"Bone cells","volume-title":"Basic and Applied Bone Biology","author":"Bellido","year":"2014"},{"key":"2019062417101274100_bib20","first-page":"315","volume-title":"Skeletal Heterogeneity and the Purposes of Bone Remodeling. Osteoporosis","author":"Parfitt","year":"1996"},{"key":"2019062417101274100_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-12-373884-4.00032-X","article-title":"Apoptosis in bone cells","volume-title":"Principles of Bone Biology","author":"Jilka","year":"2008","edition":". 3rd ed."},{"issue":"3","key":"2019062417101274100_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/me.2004-0161","article-title":"Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal","volume":"19","author":"Zhao","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"33","key":"2019062417101274100_bib23","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis","volume":"282","author":"Plotkin","year":"2007","journal-title":"J Biol Chem"},{"issue":"19","key":"2019062417101274100_bib24","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1073\/pnas.1834348100","article-title":"Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration","volume":"100","author":"Okigaki","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019062417101274100_bib25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of Sost\/sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019062417101274100_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"issue":"25","key":"2019062417101274100_bib27","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.0701421104","article-title":"Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis","volume":"104","author":"Buckbinder","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019062417101274100_bib28","doi-asserted-by":"crossref","first-page":"E478","DOI":"10.1073\/pnas.1409857112","article-title":"Osteocytes mediate the anabolic actions of canonical Wnt\/\u03b2-catenin signaling in bone","volume":"112","author":"Tu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019062417101274100_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jbmr.304","article-title":"PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling","volume":"26","author":"Rhee","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2019062417101274100_bib30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019062417101274100_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"issue":"9","key":"2019062417101274100_bib32","doi-asserted-by":"crossref","first-page":"e108262","DOI":"10.1371\/journal.pone.0108262","article-title":"Raloxifene prevents skeletal fragility in adult female Zucker Diabetic Sprague-Dawley rats","volume":"9","author":"Hill Gallant","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019062417101274100_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"issue":"10","key":"2019062417101274100_bib34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest"},{"key":"2019062417101274100_bib35","unstructured":"RRID:AB_2801263, https:\/\/scicrunch.org\/resolver\/AB_2801263."},{"key":"2019062417101274100_bib36","unstructured":"RRID:AB_2801265, https:\/\/scicrunch.org\/resolver\/AB_2801265."},{"key":"2019062417101274100_bib37","unstructured":"RRID:AB_2801266, https:\/\/scicrunch.org\/resolver\/AB_2801266."},{"key":"2019062417101274100_bib38","unstructured":"RRID:AB_2801264, https:\/\/scicrunch.org\/resolver\/AB_2801264."},{"issue":"1","key":"2019062417101274100_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2019062417101274100_bib40","doi-asserted-by":"crossref","first-page":"e0132903","DOI":"10.1371\/journal.pone.0132903","article-title":"The crosstalk between osteoclasts and osteoblasts is dependent upon the composition and structure of biphasic calcium phosphates","volume":"10","author":"Shiwaku","year":"2015","journal-title":"PLoS One"},{"key":"2019062417101274100_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2014.09.016","article-title":"Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-\/-) mice","volume":"69","author":"Hajjawi","year":"2014","journal-title":"Bone"},{"issue":"4","key":"2019062417101274100_bib42","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1074\/jbc.M805280200","article-title":"Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption","volume":"284","author":"Wilson","year":"2009","journal-title":"J Biol Chem"},{"key":"2019062417101274100_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bone.2014.12.012","article-title":"Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice","volume":"73","author":"Sato","year":"2015","journal-title":"Bone"},{"issue":"6","key":"2019062417101274100_bib44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200701148","article-title":"Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-\/-) mice","volume":"178","author":"Gil-Henn","year":"2007","journal-title":"J Cell Biol"},{"issue":"5","key":"2019062417101274100_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"issue":"8","key":"2019062417101274100_bib46","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","article-title":"11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019062417101274100_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1359\/jbmr.2002.17.6.979","article-title":"Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure","volume":"17","author":"Cooper","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019062417101274100_bib48","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2019062417101274100_bib49","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019062417101274100_bib50","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/en.2019-00237\/28598823\/en.2019-00237.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/160\/7\/1659\/28859527\/en.2019-00237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T12:43:01Z","timestamp":1569242581000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/160\/7\/1659\/5487989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,13]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,5,13]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2019-00237","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,5,13]]}}}